Last reviewed · How we verify
Artificial Tears Methylcellulose — Competitive Intelligence Brief
phase 3
Artificial tear / Lubricating agent
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Artificial Tears Methylcellulose (Artificial Tears Methylcellulose) — Vanderbilt University Medical Center. Methylcellulose forms a protective lubricating film on the ocular surface to relieve dry eye symptoms.
Comparator set (4 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Artificial Tears Methylcellulose TARGET | Artificial Tears Methylcellulose | Vanderbilt University Medical Center | phase 3 | Artificial tear / Lubricating agent | ||
| carboxymethylcellulose-based lubricant eye drops | carboxymethylcellulose-based lubricant eye drops | Allergan | marketed | Artificial tear / lubricating agent | ||
| Lubricating eyedrops containing hydroxypropyl-guar | Lubricating eyedrops containing hydroxypropyl-guar | University of Zagreb | marketed | Artificial tear / lubricating agent | ||
| Lubricating Eye Drop | Lubricating Eye Drop | Allergan | marketed | Artificial tear / lubricating agent | ||
| Placebo eye drops of 0.5% Methylcellulose | Placebo eye drops of 0.5% Methylcellulose | University of Campinas, Brazil | phase 3 | Artificial tear / Lubricating agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Artificial tear / Lubricating agent class)
- University of Campinas, Brazil · 1 drug in this class
- Vanderbilt University Medical Center · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Artificial Tears Methylcellulose CI watch — RSS
- Artificial Tears Methylcellulose CI watch — Atom
- Artificial Tears Methylcellulose CI watch — JSON
- Artificial Tears Methylcellulose alone — RSS
- Whole Artificial tear / Lubricating agent class — RSS
Cite this brief
Drug Landscape (2026). Artificial Tears Methylcellulose — Competitive Intelligence Brief. https://druglandscape.com/ci/artificial-tears-methylcellulose. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing